These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38562087)

  • 21. Managed competition in the United States: How well is it promoting equity and efficiency?
    Ellis RP; Hoagland A; Acquatella A
    Health Econ Policy Law; 2024 Jan; ():1-15. PubMed ID: 38186232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using an equity-based framework for evaluating publicly funded health insurance programmes as an instrument of UHC in Chhattisgarh State, India.
    Nandi S; Schneider H
    Health Res Policy Syst; 2020 May; 18(1):50. PubMed ID: 32450870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inequities in access to medical care in five countries: findings from the 2001 Commonwealth Fund International Health Policy Survey.
    Schoen C; Doty MM
    Health Policy; 2004 Mar; 67(3):309-22. PubMed ID: 15036818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tackling segmentation to advance universal health coverage: analysis of policy architectures of health care in Chile and Uruguay.
    Bernales-Baksai P
    Int J Equity Health; 2020 Jul; 19(1):106. PubMed ID: 32664954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restructuring primary health care markets in New Zealand: from welfare benefits to insurance markets.
    Howell B
    Aust New Zealand Health Policy; 2005 Sep; 2():20. PubMed ID: 16144544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Waiting for' and 'waiting in' public and private hospitals: a qualitative study of patient trust in South Australia.
    Ward PR; Rokkas P; Cenko C; Pulvirenti M; Dean N; Carney AS; Meyer S
    BMC Health Serv Res; 2017 May; 17(1):333. PubMed ID: 28476130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A tale of two visions: the changing fortunes of Social Health Insurance in South Africa.
    McIntyre D; Doherty J; Gilson L
    Health Policy Plan; 2003 Mar; 18(1):47-58. PubMed ID: 12582107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Managed competition" for Ireland? The single versus multiple payer debate.
    Mikkers M; Ryan P
    BMC Health Serv Res; 2014 Sep; 14():442. PubMed ID: 25261074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social health insurance contributes to universal coverage in South Africa, but generates inequities: survey among members of a government employee insurance scheme.
    Goudge J; Alaba OA; Govender V; Harris B; Nxumalo N; Chersich MF
    Int J Equity Health; 2018 Jan; 17(1):1. PubMed ID: 29301537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of private insurance in public health care systems: conceptual framework and policies].
    Rodríguez M
    Gac Sanit; 2001; 15(6):527-37. PubMed ID: 11858789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One hundred and eighteen years of the German health insurance system: are there any lessons for middle- and low-income countries?
    Bärnighausen T; Sauerborn R
    Soc Sci Med; 2002 May; 54(10):1559-87. PubMed ID: 12061488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consumers' perspectives on national health insurance in South Africa: using a mobile health approach.
    Weimann E; Stuttaford MC
    JMIR Mhealth Uhealth; 2014 Oct; 2(4):e49. PubMed ID: 25351980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualitative analysis of Iranian sixth five-year economic, social, and cultural development plan from universal health coverage perspective.
    Mahdavi M; Sajadi HS
    BMC Health Serv Res; 2021 Sep; 21(1):966. PubMed ID: 34521388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of three general practitioner contracting-in models in South Africa: a qualitative multi-case study.
    Mureithi L; Burnett JM; Bertscher A; English R
    Int J Equity Health; 2018 Oct; 17(1):107. PubMed ID: 30286772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the design of China's complex health system - Concerns on equity and efficiency.
    Wang Y; Castelli A; Cao Q; Liu D
    Health Policy Open; 2020 Dec; 1():100021. PubMed ID: 37383318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The politics of managed competition: public abuse of the private interest.
    Robinson JC
    J Health Polit Policy Law; 2003; 28(2-3):341-53. PubMed ID: 12836889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Access to elective surgery in New Zealand: considering equity and the private and public mix.
    Derrett S; Bevin TH; Herbison P; Paul C
    Int J Health Plann Manage; 2009; 24(2):147-60. PubMed ID: 19322811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insurance status and waiting times for hospital-based services in Ireland.
    Whyte R; Connolly S; Wren MA
    Health Policy; 2020 Nov; 124(11):1174-1181. PubMed ID: 32682572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors for Consideration When Setting Prices for Private Healthcare Providers Operating in Public Systems: A Comparison of France and Japan.
    Honda A; Cartailler J; Cailhol J; Noda S; Or Z
    Health Serv Insights; 2023; 16():11786329231173484. PubMed ID: 37228260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.